Search Results for: SPS Zertifizierungsprüfung 🅿 SPS Dumps ⌨ SPS Originale Fragen 👽 Öffnen Sie 《 www.itzert.com 》 geben Sie [ SPS ] ein und erhalten Sie den kostenlosen Download 🔪SPS Deutsch
FDA Approves WAINUAâ„¢ (Eplontersen) for Treatment of Hereditary ATTR Amyloidosis Polyneuropathy
BREAKING NEWS: The U.S. Food and Drug Administration has approved AstraZeneca and Ionis’ WAINUA™ (eplontersen) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults, commonly referred to as hATTR-PN or ATTRv-PN. WAINUA™ (eplontersen) is a Ligand-Conjugated Antisense medicine designed to prevent the production of the transthyretin (TTR) protein. The treatment attaches to and blocks RNA in liver cells, meaning the cells do not receive instructions to make more TTR protein. This reduces the amount of TTR protein...
Read More
2024 Programs
Read More
An ARC Fireside Chat
In this ARC TALKS webinar, the dedicated team behind the transformative initiatives of ARC discuss the impactful work of the Leadership, Research, Development, Communications, and Community Alliance departments.
Read More
2024 Grants & Sponsorship Opportunities
Read More
[WPB Confirm] Dinner with ARC
Read More